<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01912573</url>
  </required_header>
  <id_info>
    <org_study_id>N3OD</org_study_id>
    <secondary_id>Ohio Division of EMS Board</secondary_id>
    <nct_id>NCT01912573</nct_id>
  </id_info>
  <brief_title>Nasal Naloxone for Narcotic Overdose</brief_title>
  <official_title>Nasal Naloxone for Narcotic Overdose</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Judith Feinberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Cincinnati</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to determine if nasal naloxone is inferior to standard care for
      naloxone administration in a pre-hospital setting. Ambulance squads in Adams, Clermont, and
      Scioto counties in southern Ohio will be randomized to provide either standard care or nasal
      (IN) naloxone as the initial response to a suspected opioid overdose. Standard care includes
      administration of naloxone by intravenous (IV), intramuscular (IM) or intraosseus (IO)
      methods.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized, prospective trial that will compare clinical outcomes for parenteral
      naloxone according to the standard of care (TAU; administration via intravenous [IV],
      intramuscular [IM] or intraosseus [IO] delivery) versus intranasal [IN] for the prehospital
      emergency treatment of suspected opioid overdose. Ambulance squads in Adams, Clermont, and
      Scioto counties in southern Ohio will be randomized to administer either standard care or IN
      naloxone as the initial response to a suspected opioid overdose.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">March 2015</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of patients with adequate respiration within 10 minutes</measure>
    <time_frame>10 minutes after intervention administration</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients requiring second dose of naloxone</measure>
    <time_frame>within 10 minutes of initial dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first naloxone administration</measure>
    <time_frame>at baseline</time_frame>
    <description>Time between emergency call and administration of naloxone.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid Withdrawal Symptoms</measure>
    <time_frame>baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Naloxone Adverse Events</measure>
    <time_frame>3 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of Patients breathing unassisted upon arrival to the hospital</measure>
    <time_frame>within 1 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days of hospitalization following naloxone administration</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality rate</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">236</enrollment>
  <condition>Drug Overdose</condition>
  <arm_group>
    <arm_group_label>Intranasal (IN) naloxone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intranasal (IN) naloxone as initial response to suspected opioid overdose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care (TAU)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard of care (intravenous [IV], intramuscular [IM] or intraosseus [IO]delivery of naloxone) as initial response to suspected opioid overdose.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intranasal (IN) naloxone</intervention_name>
    <arm_group_label>Intranasal (IN) naloxone</arm_group_label>
    <other_name>Narcan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous (IV) naloxone</intervention_name>
    <arm_group_label>Standard of Care (TAU)</arm_group_label>
    <other_name>Narcan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intramuscular (IM) naloxone</intervention_name>
    <arm_group_label>Standard of Care (TAU)</arm_group_label>
    <other_name>Narcan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intraosseus (IO) naloxone</intervention_name>
    <arm_group_label>Standard of Care (TAU)</arm_group_label>
    <other_name>Narcan</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Presence of hyperventilation or respiratory arrest OR

          -  EMS assessment that the person needs naloxone for possible opioid or unknown drug
             overdose

        Exclusion Criteria:

          -  EMS assessment that the participant is less than 12 years old
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Judith Feinberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cincinnati</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clermont County</name>
      <address>
        <city>Batavia</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Joe Renusch, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Scioto County</name>
      <address>
        <city>Portsmouth</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Brian Barhorst, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Adams County</name>
      <address>
        <city>West Union</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bruce Ashley, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 29, 2013</study_first_submitted>
  <study_first_submitted_qc>July 29, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 31, 2013</study_first_posted>
  <last_update_submitted>July 29, 2013</last_update_submitted>
  <last_update_submitted_qc>July 29, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 31, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Cincinnati</investigator_affiliation>
    <investigator_full_name>Judith Feinberg</investigator_full_name>
    <investigator_title>Assoc Chair of Medicine</investigator_title>
  </responsible_party>
  <keyword>heroin</keyword>
  <keyword>prescription pain killers</keyword>
  <keyword>narcotics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Drug Overdose</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Naloxone</mesh_term>
    <mesh_term>Narcotics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

